Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa massachusetts
  4. colitis uc
Show results for
Products
Services
Applications

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Massachusetts
Brands

  • seres
  • finch
Applications

  • Microbiome Therapeutics for Patients and Physicians
  • Microbiome Therapeutics for Clinical Trials

Colitis Uc Equipment Supplied In Usa Massachusetts

3 equipment items found
In MassachusettsAvailable In MassachusettsNear Massachusetts

Seres - Model SER-301 - Investigational, Oral, Rationally-Designed, Fermented Microbiome Therapeutic Ulcerative Colitis

Seres - Model SER-301 - Investigational, Oral, Rationally-Designed, Fermented Microbiome Therapeutic Ulcerative Colitis

Manufactured by:Seres Therapeutics, Inc.   based inCambridge, MASSACHUSETTS (USA)
SER-301 is an investigational, oral, rationally-designed, fermented microbiome therapeutic for the treatment of mild-to-moderate ulcerative colitis (UC). SER-301 is a consortium of multiple bacterial strains that is manufactured by fermenting each strain individually and then combining to form drug product. ...
CONTACT SUPPLIER

Finch - Model TAK-524 & FIN-525 - Microbiome Therapeutics for Inflammatory Bowel Disease (IBD)

Finch - Model TAK-524 & FIN-525 - Microbiome Therapeutics for Inflammatory Bowel Disease (IBD)

Manufactured by:Finch Therapeutics Group, Inc.   based inSomerville, MASSACHUSETTS (USA)
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD), respectively. UC and CD are the two most common types of IBD, an autoimmune condition that causes inflammation of the ...
CONTACT SUPPLIER

Seres - Model SER-287 - Investigational, Oral, Biologically-Derived Microbiome Therapeutic Ulcerative Colitis

Seres - Model SER-287 - Investigational, Oral, Biologically-Derived Microbiome Therapeutic Ulcerative Colitis

Manufactured by:Seres Therapeutics, Inc.   based inCambridge, MASSACHUSETTS (USA)
SER-287 is an investigational, oral, biologically-derived microbiome therapeutic for the treatment of ulcerative colitis (UC). SER-287 is a consortium of multiple bacterial spores manufactured by fractionating and purifying targeted bacteria from stool of healthy human donors. SER-287 has been granted Fast Track designation and Orphan Drug designation by the ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT